<div id="readability-page-1"><p>DAVENPORT &amp; Co LLC lifted its stake in shares of  HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 23.9% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 386,388 shares of the company's stock after acquiring an additional 74,431 shares during the quarter. DAVENPORT &amp; Co LLC owned about 0.45% of HealthEquity worth $36,773,000 at the end of the most recent reporting period.</p><ul><li>Russell 2000 Surge Post-Election: How to Play the Small-Cap Pop</li></ul><p>Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in HQY. Price T Rowe Associates Inc. MD boosted its stake in  HealthEquity by 995.6% during the first quarter. Price T Rowe Associates Inc. MD now owns 639,345 shares of the company's stock valued at $56,500,000 after buying an additional 580,988 shares in the last quarter.  Westfield Capital Management Co. LP lifted its holdings in  HealthEquity by 124.6% in the 2nd quarter. Westfield Capital Management Co. LP now owns 1,265,208 shares of the company's stock valued at $132,543,000 after acquiring an additional 701,819 shares during the last quarter.  Banco Bilbao Vizcaya Argentaria S.A. bought a new position in shares of  HealthEquity during the 2nd quarter valued at about $492,000.  Artisan Partners Limited Partnership boosted its position in shares of  HealthEquity by 44.8% during the 2nd quarter. Artisan Partners Limited Partnership now owns 621,647 shares of the company's stock valued at $65,124,000 after purchasing an additional 192,252 shares in the last quarter.  Finally, Ashford Capital Management Inc. grew its stake in shares of  HealthEquity by 2.1% in the 1st quarter. Ashford Capital Management Inc. now owns 274,999 shares of the company's stock worth $24,302,000 after purchasing an additional 5,687 shares during the last quarter. Institutional investors own  99.55% of the company's stock. </p><h2>Insiders Place Their Bets</h2><p>In other news, EVP Elimelech Rosner sold 10,959 shares of the stock in a transaction that occurred on Thursday, December 18th. The shares were sold at an average price of $95.45, for a total value of $1,046,036.55. Following the completion of the sale, the executive vice president directly owned 45,742 shares of the company's stock, valued at $4,366,073.90. This represents a 19.33% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities &amp; Exchange Commission, which can be accessed through this link. Also, EVP Delano Ladd sold 1,500 shares of the firm's stock in a transaction that occurred on Friday, December 19th. The stock was sold at an average price of $94.72, for a total transaction of $142,080.00. Following the sale, the executive vice president owned 73,979 shares of the company's stock, valued at approximately $7,007,290.88. This represents a 1.99% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last ninety days, insiders sold 17,240 shares of company stock worth $1,640,164. 1.50% of the stock is currently owned by company insiders. </p><h2>HealthEquity Trading Down 1.2%</h2><ul><li>2 Recession-Resistant Stocks for Tough Market Conditions</li></ul><p>NASDAQ HQY opened at $92.69 on Wednesday. The firm's 50 day moving average price is $97.21 and its two-hundred day moving average price is $96.05. The company has a debt-to-equity ratio of 0.46, a quick ratio of 4.13 and a current ratio of 4.13. HealthEquity, Inc. has a twelve month low of $74.07 and a twelve month high of $116.65. The stock has a market cap of $7.92 billion, a price-to-earnings ratio of 42.52, a PEG ratio of 1.36 and a beta of 0.18. </p><p>HealthEquity (NASDAQ:HQY - Get Free Report) last released its earnings results on Wednesday, December 3rd. The company reported $1.01 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.90 by $0.11. HealthEquity had a return on equity of 12.94% and a net margin of 14.86%.The company had revenue of $322.16 million during the quarter, compared to analyst estimates of $320.92 million. During the same quarter in the prior year, the company earned $0.78 earnings per share. The company's revenue for the quarter was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS.  Equities analysts anticipate that  HealthEquity, Inc. will post 2.32 EPS for the current year. </p><h2>Analysts Set New Price Targets</h2><ul><li>HealthEquity Stock: Leading Health Savings Account Investment</li></ul><p>Several research firms recently commented on HQY. Barrington Research  reissued an &#34;outperform&#34; rating and set a $125.00 target price on shares of HealthEquity in a research note on Thursday, December 4th. Barclays started coverage on HealthEquity in a research report on Monday, December 8th. They set an &#34;overweight&#34; rating and a $118.00 price objective for the company. Wall Street Zen cut HealthEquity from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a report on Saturday, November 15th. JPMorgan Chase &amp; Co. boosted their target price on HealthEquity from $126.00 to $129.00 and gave the stock an &#34;overweight&#34; rating in a research report on Thursday, December 4th. Finally, BTIG Research  reaffirmed a &#34;buy&#34; rating and set a $130.00 target price on shares of HealthEquity in a report on Thursday, December 4th. Two equities research analysts have rated the stock with a Strong Buy rating, twelve have assigned  a Buy rating and three have issued  a Hold rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of &#34;Moderate Buy&#34; and an average price target of $120.27.</p><p><b>Check Out Our Latest Report on HealthEquity</b></p><h2>HealthEquity Profile</h2> (Free Report)<p>HealthEquity, Inc <span>NASDAQ: HQY<span></span></span> is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.  </p><p>Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.</p><h2>Featured Articles</h2><ul><li>Five stocks we like better than HealthEquity</li><li>The boring AI play that could pay up to $4,290 monthly</li><li>Trump’s “real estate deal for America” explained</li><li>Put $1,000 into this stock by Jan 1 [Not NVDA]</li><li>ALERT: Drop these 5 stocks before January 2026!</li><li>Trump Did WHAT??</li></ul><p><strong>Want to see what other hedge funds are holding HQY?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY - Free Report).</p><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SFFZ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SFFZ"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in HealthEquity Right Now?</h2><p>Before you consider HealthEquity, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HealthEquity wasn't on the list.</p><p>While HealthEquity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>DAVENPORT & Co LLC increased its stake in HealthEquity, Inc. by 23.9% in Q3, owning 386,388 shares valued at $36.77 million. Other institutional investors also adjusted their holdings. HealthEquity's stock opened at $92.69, with a market cap of $7.92 billion. The company reported Q3 earnings of $1.01 per share, surpassing estimates, and revenue of $322.16 million, up 7.2% year-over-year. Analysts set a price target of $125.00 for the stock.</p>

HealthEquity, Inc. $HQY Shares Bought by DAVENPORT & Co LLC